Leo Pharma makes new push for older treatment with brand new trial concept
Four years after the launch of Enstilar, a psoriasis treatment, Leo Pharma hopes to give the product a significant lift with data for a new treatment concept using the medicine.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY CATHERINE BRETT
Although Leo Pharma is repositioning itself as a developer and manufacturer of biological treatments to a larger and larger degree, the company has not turned its back on its older products.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg)
